FR2975913A1 - Agent, useful e.g. to treat neuropathic pain, cramp, traumatic hematoma, toxic, muscle soreness and polyneuritis, comprises a combination of lavender and rosemary oils, and ethanol - Google Patents

Agent, useful e.g. to treat neuropathic pain, cramp, traumatic hematoma, toxic, muscle soreness and polyneuritis, comprises a combination of lavender and rosemary oils, and ethanol Download PDF

Info

Publication number
FR2975913A1
FR2975913A1 FR1101718A FR1101718A FR2975913A1 FR 2975913 A1 FR2975913 A1 FR 2975913A1 FR 1101718 A FR1101718 A FR 1101718A FR 1101718 A FR1101718 A FR 1101718A FR 2975913 A1 FR2975913 A1 FR 2975913A1
Authority
FR
France
Prior art keywords
polyneuritis
combination
ethanol
lavender
toxic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR1101718A
Other languages
French (fr)
Other versions
FR2975913B1 (en
Inventor
Andre Francois Molinier
Jerome Santoul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR1101718A priority Critical patent/FR2975913B1/en
Publication of FR2975913A1 publication Critical patent/FR2975913A1/en
Application granted granted Critical
Publication of FR2975913B1 publication Critical patent/FR2975913B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Agent comprises a combination of lavender and rosemary oils, and ethanol. ACTIVITY : Analgesic; Antiinflammatory; Neuroprotective; Antianemic; Muscular-Gen. MECHANISM OF ACTION : None given.

Description

Procédé therapeutique pour 1'antalgie des douleurs de type neuropathique (Crampes - Courbatures - Polynévrite ) ------------- Agent therapeutique qui comprend une combinaison d'huiles essentielles de Tavauderde Romarineainsi que l'éthanol. La Formule obtenue permet de réduire les sensations neuropathiques à type de polynévrites. Effets analgésiques de la formule sur les fibres longues et courtes du système ne-r,_veux,elles permettent une action antalgique. L'antalgie est notée sur les crampes de différents types: -Traumatique (Hématome ) -Toxique (accumulation d'acide lactique suite à un effort soutenu du muscle, en anaérobie ) -Neuropathique dans les polynévrites dont les plus courantes sont les crampes nocturnes des muscles des membres inférieurs. !muscle en anaérobie) Neuropatique dans les polynévrites dont les plus courantes sont les icrampes nocturnes des muscles des membres inférieure, 3em revendication: Aent thérapeutique selOri revendication Un, L'antalgie est notée sur les crampes de différents typas; -Traumatique (Hématome) -Toxique «accumulation d1acidmlaotiqua suite à un éffort soutenu du Therapeutic method for the analgia of neuropathic pain (Cramps - Aches - Polyneuritis) ------------- A therapeutic agent which comprises a combination of essential oils of Tavauderde Rosemary and ethanol. The formula obtained reduces neuropathic sensations type polyneuritis. Analgesic effects of the formula on the long and short fibers of the system do not allow for an analgesic action. The analgesic is noted on the cramps of different types: -Traumatic (Hematoma) -Toxic (accumulation of lactic acid following a sustained effort of the muscle, in anaerobic) -Neuropathic in the polynévrites whose most current are the night cramps of the muscles of the lower limbs. anaerobic muscle) Neuropatic polyneuritis, the most common of which are nocturnal cramps of the muscles of the lower limbs, 3em claim: Therapeutic ale selOri claim One, The analgesia is noted on the cramps of different typas; -Traumatic (Hematoma) -Toxic "accumulation of acidmlaotiqua following a sustained effort of

Claims (2)

REVENDICATIONS1. Agent thérapeutique qui conprend ume combinaison REVENDICATIONS1. Agent thérapeutique qui conprend ume combinaison d'huiles essentielles de Lævanda,de Romarin,ainsi que l"éthonoI, Cette fermulo obtenue permet de réduire les sensations neuropathiques type de polynévrites. REVENDICATIONS1. Therapeutic agent that includes a combination CLAIMS1. Therapeutic agent that includes a combination of Lævanda essential oils, Rosemary, and ethonoI, This fermulo obtained reduces the neuropathic sensations type of polyneuritis. 2. Agent therapeutique,selon revendication Un, qui peut atténuer la douleur de type næuropothïque Crampes,, Courbatures ,- Polynévrite ) Effet analgésique de la formule sur les fibres longues et courtes du système nerveux,elles permettent uns action antalgique, 2. Therapeutic agent, according to claim 1, which can alleviate the neuropathic-type pain. Cramps, aches, polyneuritis) Analgesic effect of the formula on the long and short fibers of the nervous system, they allow an analgesic action,
FR1101718A 2011-06-01 2011-06-01 THERAPEUTIC AGENT BASED ON ESSENTIAL OILS OF LAVENDER AND ROSEMARY AND ETHANOL AGAINST PAIN CAUSED BY CRAMPS Expired - Fee Related FR2975913B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1101718A FR2975913B1 (en) 2011-06-01 2011-06-01 THERAPEUTIC AGENT BASED ON ESSENTIAL OILS OF LAVENDER AND ROSEMARY AND ETHANOL AGAINST PAIN CAUSED BY CRAMPS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1101718A FR2975913B1 (en) 2011-06-01 2011-06-01 THERAPEUTIC AGENT BASED ON ESSENTIAL OILS OF LAVENDER AND ROSEMARY AND ETHANOL AGAINST PAIN CAUSED BY CRAMPS

Publications (2)

Publication Number Publication Date
FR2975913A1 true FR2975913A1 (en) 2012-12-07
FR2975913B1 FR2975913B1 (en) 2014-05-02

Family

ID=45375312

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1101718A Expired - Fee Related FR2975913B1 (en) 2011-06-01 2011-06-01 THERAPEUTIC AGENT BASED ON ESSENTIAL OILS OF LAVENDER AND ROSEMARY AND ETHANOL AGAINST PAIN CAUSED BY CRAMPS

Country Status (1)

Country Link
FR (1) FR2975913B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000025036A1 (en) * 2020-10-22 2022-04-22 Nyuma Pharma Srl ASSOCIATION OF PLANTS AND THEIR USE IN THE TREATMENT OF CHRONIC PERSISTENT OR NEUROPATHIC PAIN.

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2218M (en) * 1962-01-24 1963-12-23 Gilbert Composition based on vegetable essences.
CA2208236A1 (en) * 1997-06-18 1998-12-18 Jacob Toews Massage lotion
FR2783715A1 (en) * 1998-09-29 2000-03-31 Rinrone Ets Composition for external use for treating wounds and burns, contains mixture of plant tinctures and essential oils and a local anesthetic having an immediate short term action
RU2283089C1 (en) * 2005-03-03 2006-09-10 Общество с ограниченной ответственностью "Фарм-Лад" Ointment for topical application
US20100119633A1 (en) * 2008-11-12 2010-05-13 Mccloskey Desiree Astorino Analgesic oil containing plant based extracts from solar infusions
WO2010089046A1 (en) * 2009-02-09 2010-08-12 Doris Barnikol-Keuten In situ preparations forming bonding gel, in particular for topical application to moistened skin/mucous membranes

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2218M (en) * 1962-01-24 1963-12-23 Gilbert Composition based on vegetable essences.
CA2208236A1 (en) * 1997-06-18 1998-12-18 Jacob Toews Massage lotion
FR2783715A1 (en) * 1998-09-29 2000-03-31 Rinrone Ets Composition for external use for treating wounds and burns, contains mixture of plant tinctures and essential oils and a local anesthetic having an immediate short term action
RU2283089C1 (en) * 2005-03-03 2006-09-10 Общество с ограниченной ответственностью "Фарм-Лад" Ointment for topical application
US20100119633A1 (en) * 2008-11-12 2010-05-13 Mccloskey Desiree Astorino Analgesic oil containing plant based extracts from solar infusions
WO2010089046A1 (en) * 2009-02-09 2010-08-12 Doris Barnikol-Keuten In situ preparations forming bonding gel, in particular for topical application to moistened skin/mucous membranes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200676, Derwent World Patents Index; AN 2006-743719, XP002671172 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000025036A1 (en) * 2020-10-22 2022-04-22 Nyuma Pharma Srl ASSOCIATION OF PLANTS AND THEIR USE IN THE TREATMENT OF CHRONIC PERSISTENT OR NEUROPATHIC PAIN.
WO2022084811A1 (en) * 2020-10-22 2022-04-28 Nyuma Pharma Srl Combination of plants and their use in the treatment of chronic persistent or neuropathic pain

Also Published As

Publication number Publication date
FR2975913B1 (en) 2014-05-02

Similar Documents

Publication Publication Date Title
EA201391623A1 (en) TRANSVERSE COMPOSITIONS IBUPROFENA AND METHODS OF THEIR APPLICATION
MA32056B1 (en) Stop oral medications that contain paracetamol and ibuprofen
EA201290865A1 (en) APPLICATION OF LEVODOPA, CARBIDOPE AND ENTACAPON TO TREAT PARKINSON'S DISEASE
MX360289B (en) Tapentadol compositions.
EA201391581A1 (en) METHODS FOR THE TREATMENT OF ALZGEIMER'S DISEASE, HANTINGTON'S DISEASE, AUTISM AND OTHER DISORDERS
GB2453188A (en) Formulations for treatment of adipose tissue, cutaneous tissue and disorders, and muscular tissue
EA200802412A1 (en) THERAPEUTIC COMBINATIONS FOR SUPPORTING MEDICAL CONDITIONS
EA201000603A1 (en) APPLICATION OF ANTIBODIES TO TRKB FOR THE TREATMENT OF RESPIRATORY DISTURBANCES
BR112016014481A2 (en) cancer treatment using combinations of erk and raf inhibitors
EA201071231A1 (en) CARBOXAMIDE CONNECTIONS FOR THE TREATMENT OF METABOLIC DEVICES
ECSP11011016A (en) DOSAGE FORMS OF TAPENTADOL NOVEDOSAS Y POTENTES
MA33295B1 (en) NEW FORMULATION OF DICLOFENAC
RU2010143864A (en) METHODS OF TREATING DISORDERS WITH THE APPLICATION OF THE NR2B-SELECTIVE ANTAGONIST OF NMDA RECEPTORS
EA200802020A1 (en) TETRAHYDROPYRIMIDAOZEPINA AND THEIR APPLICATION AS TRPV 1 MODULATORS
JP2008534503A5 (en)
EA201300988A1 (en) SOFT PHARMACEUTICAL COMPOSITION ON WATER BASIS CONTAINING TAPENTADOL
TW201144304A (en) Use of meloxicam for the long-term treatment of kidney disorders in cats
TNSN07430A1 (en) SYNERGISTIC ASSOCIATIONS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS WITH ALPHA-2-DELTA LIGANDS
EP2593102A4 (en) Oxazole derivatives useful as modulators of faah
MA34815B1 (en) COMPOSITIONS COMPRISING A PI3K INHIBITOR AND A MEK INHIBITOR AND THEIR USE FOR THE TREATMENT OF CANCER
CY1111588T1 (en) Substituted Carboxamides as Concentrators of Converter I
ATE531366T1 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT, REDUCTION, IMPROVEMENT OR RELIEF OF POSTERIOR EYE SEGMENT DISEASES
FR2975913A1 (en) Agent, useful e.g. to treat neuropathic pain, cramp, traumatic hematoma, toxic, muscle soreness and polyneuritis, comprises a combination of lavender and rosemary oils, and ethanol
UA112418C2 (en) THERAPEUTIC DISEASE
TNSN08385A1 (en) Delayed-release glucocorticoid treatment of rheumatoid disease

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160229